Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Completeness of reporting trial results: effect on physicians' willingness to prescribe

Bobbio, M., Demichelis, B., Giustetto, G.·1994·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(94)92407-4

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 24

  1. Forrow, 1992, Absolutely relative: How research results are summarized can affect treatment decisions, Am J Med, 92, 121, 10.1016/0002-9343(92)90100-P · DOI · Paper page
  2. Naylor, 1992, Measured enthusiasm: does the method of reporting trial results alter perception of therapeutic effectiveness?, Ann Intern Med, 117, 916, 10.7326/0003-4819-117-11-916 · DOI · Paper page
  3. Vergani, 1991, Prevenzione della malattia coronarica: l'importanza della terapia continuativa normolipemizzante, JAMA (Italian Edition), 6, 3
  4. Comroe, 1978, The road from research to new diagnosis and therapy, Science, 200, 931, 10.1126/science.644335 · doi:10.1126/science.644335
  5. Feinstein, 1988, Fraud, distortion, delusion, and consensus; the problems of human on natural deception in epidemiologic science, Am J Med, 84, 475, 10.1016/0002-9343(88)90268-9 · DOI
  6. Weissler, 1989, The need for clarification of percent risk reduction data in clinical cardiovascular trial reports, J Am Coll Cardiol, 13, 764, 10.1016/0735-1097(89)90623-2 · DOI
  7. Pickering, 1983, Treatment of mild hypertension and the reduction of cardiovascular mortality: the 'of' or 'by' dilemma, JAMA, 249, 399, 10.1001/jama.1983.03330270063039 · doi:10.1001/jama.1983.03330270063039
  8. Brett, 1989, Treating hypercholesterolemia. How should practising physicians interpret the published data for patients?, N Engl J Med, 321, 676, 10.1056/NEJM198909073211009 · DOI
  9. Feinstein, 1992, Invidious comparisons and unmet clinical challenges, Am J Med, 92, 117, 10.1016/0002-9343(92)90099-W · DOI
  10. DerSimonian, 1982, Reporting on methods in clinical trials, N Engl J Med, 306, 1332, 10.1056/NEJM198206033062204 · DOI · Paper page
  11. Bobbio, 1992, It is still controversial which is the correct way to report and to interpret event rates of clinical trials (letter), Int J Cardiol, 37, 125, 10.1016/0167-5273(92)90145-S · DOI
  12. Figon, 1992, Doctors' perception of pertinent information. Results of a survey of a random sample of French general practitioners, Eur J Clin Pharmacol, 43, 113, 10.1007/BF01740654 · doi:10.1007/bf01740654
  13. Hsia, 1990, A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infaction, N Engl J Med, 323, 1433, 10.1056/NEJM199011223232101 · DOI · Paper page
  14. The European Infarction Study Group, 1982, A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality, Eur Hear J, 3, 583
  15. The Danish Study Group on Verapamil on Myocardial Infarction, 1990, Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT II), Am J Cardiol, 66, 779, 10.1016/0002-9149(90)90351-Z · DOI · Paper page
  16. Lichtlen, 1990, Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Atherosclerotic therapy (INTACT), Lancet, 335, 1109, 10.1016/0140-6736(90)91121-P · DOI · Paper page
  17. Eraker, 1981, Assessment of patients' preferences for therapeutic outcomes, Med Decis Making, 1, 29, 10.1177/0272989X8100100105 · DOI
  18. Nightingale, 1988, Risk preference and decision making in crtitical care situations, Chest, 93, 684, 10.1378/chest.93.4.684 · DOI
  19. Forrow, 1988, Science, ethics, and the making of clinical decisions. Implications for risk factor intervention, JAMA, 259, 3161, 10.1001/jama.1988.03720210051029 · DOI
  20. McNeil, 1982, On the elicitation of preferences for alternative therapies, N Engl J Med, 306, 1259, 10.1056/NEJM198205273062103 · DOI · Paper page
  21. Redelmaier, 1990, Discrepancy between medical decision for individual patients and for groups, N Engl J Med, 322, 1262
  22. Brock, 1990, When competent patients make irrational choices, N Engl J Med, 322, 1595, 10.1056/NEJM199005313222209 · DOI · Paper page
  23. Safavi, 1992, Choosing between apples and apples: physicians' choices of prescription drugs that have similar side effects and efficacies, J Gen Intern Med, 7, 32, 10.1007/BF02599099 · DOI
  24. Chinburapa, 1992, The importance of side effects and outcomes in differentiating between prescription drug products, J Clin Pharm Ther, 17, 333, 10.1111/j.1365-2710.1992.tb01314.x · doi:10.1111/j.1365-2710.1992.tb01314.x

Cited by

See all 188

Metadata

Authors
Bobbio, M., Demichelis, B., & Giustetto, G.
Venue
The Lancet
Publisher
Elsevier BV
Published
1994-05
Volume
343
Issue
8907
Pages
1209-1211
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2000712401
Cited by
188
References
4
FWCI
8.25
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Completeness of reporting trial results: effect on physicians' willingness to prescribe. https://app.cochat.ai/papers/10.1016/s0140-6736(94)92407-4
The paper
Bobbio, M., Demichelis, B., & Giustetto, G. (1994). Completeness of reporting trial results: effect on physicians' willingness to prescribe. The Lancet. https://doi.org/10.1016/s0140-6736(94)92407-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.